Cureline, Inc. (South San Francisco, CA) has been selected to join a group of U.S. companies heading to Africa for the U.S. Department of Commerce-led Trade Winds—Africa trade mission and business forum.
“Africa presents an incredible opportunity for global U.S. companies,” said Regional Senior U.S. Commercial Officer Donald Nay, the highest-ranking commercial diplomat in Sub-Saharan Africa. “We are excited to bring these companies to the continent, connect them to promising opportunities, and get them on the right path to success”. Trade Winds is an important part of the United States’ Doing Business in Africa campaign, under which the government has committed billions of dollars to development initiatives in Africa, and has facilitated billions more in U.S.-Africa business deals.
Cureline is a global commercial biobank providing solutions for precision medicine. With human tissues biorepository (USA) and clinical network in 16 countries, Cureline specializes in contract services for human sample validation studies: biobanking, laboratory services and logistics. Cureline team will participate in the Trade Winds business forum and series of meetings in Johannesburg, South Africa. “Cureline has been envisioning expansion of its clinical operations to Africa for a while, and we are very excited to join this mission and find inroads to success in this challenging continent” said Cureline CEO and Scientific Director Dr. Olga Potapova, who founded the company 12 years ago. With start of business in Africa, Cureline will provide the most diverse range of human biospecimens for research applications worldwide.